Baxter’s Vero Cell Seasonal Flu #Vaccine Preflucel Approved in 13 European Countries

[Guest guest]

Vero Cells - VERO cells are derived from kidney cells of African

green monkeys

http://www.health-know.org/index.php/group_thread/view/id-18531

" VERO cells are derived from kidney cells of African green monkeys.

FluBlok is made from insect cells (caterpillar eggs). MDCK cells are

created from a dog s kidney. Cells have been immortalized and divided

since 1959. PER.C6 are manufactured for Crucell. The cell line is derived

from a single human retina cell from an aborted fetus. PER.C6 cells are

com

bined with an adenovirus to create a number of cells called a designer

substrate or oncogenic cells that have the potential to get

cancer. These cells have caused tumors when injected into

experimental animals. "

http://blogs.terrapinn.com/vaccinenation/2011/03/04/baxters-vero-cell-seasonal-flu-vaccine-preflucel-approved-13-european-countries/

Baxter’s Vero Cell Seasonal Flu #Vaccine Preflucel Approved in

13 European Countries

Baxter’s Preflucel

seasonal flu vaccine has just been approved in 13 European countries

via the repeat

mutual recognition procedure (rMRP). Baxter says the latest countries

in which the drug is now approved will implement the license in order to

make

Preflucel available for the 2011-12 flu season. These countries

include Germany, Spain, the U.K. and Nordic countries.

Preflucel comprises purified, inactivated split

influenza virions, and is manufactured using Baxter’s mammalian cell

line-based Vero cell platform. Data from a U.S. Phase III study in over

7,200 healthy individuals has shown Preflucel provided 78.5% protective

efficacy against subsequent culture-confirmed influenza infection, and

robust immune responses against the three viral strains contained in the

vaccine.

In December 2010

Baxter and Takeda Pharmaceutical inked a development, license, and

technology transfer agreement that essentially expands their previous

collaboration to develop Vero cell culture-based flu vaccines for the

Japanese market. Under terms of the new deal the companies are

jointly developing an H5N1 flu vaccine, and Takeda is pursuing Japanese

government funding for the construction of a Vero cell-based flu

manufacturing facility in Japan.

Read the complete article

Dr Frech,

Head, Vaccines Therapeutic Area, Global Clinical Development and Medical

Affairs at Baxter BioScience will be discussing Vero Cell derived

pandemic influenza vaccines at the 11th annual

World Vaccine Congress Washington in April.

Download the video presentation here

Tags:

baxter

, flu,

Influenza,

Vaccination,

Vaccine,

Vaccines,

vero

cell

Posted 4 days ago by

Wallace

Sheri Nakken, former R.N., MA, Hahnemannian

Homeopath

Vaccination Information & Choice Network, Washington State, USA

Vaccines -

http://vaccinationdangers.wordpress.com/ Homeopathy

http://homeopathycures.wordpress.com

Vaccine Dangers, Childhood Disease Classes & Homeopathy

Online/email courses - next classes start March 4

[Guest guest]

Vero Cells - VERO cells are derived from kidney cells of African

green monkeys

http://www.health-know.org/index.php/group_thread/view/id-18531

" VERO cells are derived from kidney cells of African green monkeys.

FluBlok is made from insect cells (caterpillar eggs). MDCK cells are

created from a dog s kidney. Cells have been immortalized and divided

since 1959. PER.C6 are manufactured for Crucell. The cell line is derived

from a single human retina cell from an aborted fetus. PER.C6 cells are

com

bined with an adenovirus to create a number of cells called a designer

substrate or oncogenic cells that have the potential to get

cancer. These cells have caused tumors when injected into

experimental animals. "

http://blogs.terrapinn.com/vaccinenation/2011/03/04/baxters-vero-cell-seasonal-flu-vaccine-preflucel-approved-13-european-countries/

Baxter’s Vero Cell Seasonal Flu #Vaccine Preflucel Approved in

13 European Countries

Baxter’s Preflucel

seasonal flu vaccine has just been approved in 13 European countries

via the repeat

mutual recognition procedure (rMRP). Baxter says the latest countries

in which the drug is now approved will implement the license in order to

make

Preflucel available for the 2011-12 flu season. These countries

include Germany, Spain, the U.K. and Nordic countries.

Preflucel comprises purified, inactivated split

influenza virions, and is manufactured using Baxter’s mammalian cell

line-based Vero cell platform. Data from a U.S. Phase III study in over

7,200 healthy individuals has shown Preflucel provided 78.5% protective

efficacy against subsequent culture-confirmed influenza infection, and

robust immune responses against the three viral strains contained in the

vaccine.

In December 2010

Baxter and Takeda Pharmaceutical inked a development, license, and

technology transfer agreement that essentially expands their previous

collaboration to develop Vero cell culture-based flu vaccines for the

Japanese market. Under terms of the new deal the companies are

jointly developing an H5N1 flu vaccine, and Takeda is pursuing Japanese

government funding for the construction of a Vero cell-based flu

manufacturing facility in Japan.

Read the complete article

Dr Frech,

Head, Vaccines Therapeutic Area, Global Clinical Development and Medical

Affairs at Baxter BioScience will be discussing Vero Cell derived

pandemic influenza vaccines at the 11th annual

World Vaccine Congress Washington in April.

Download the video presentation here

Tags:

baxter

, flu,

Influenza,

Vaccination,

Vaccine,

Vaccines,

vero

cell

Posted 4 days ago by

Wallace

Sheri Nakken, former R.N., MA, Hahnemannian

Homeopath

Vaccination Information & Choice Network, Washington State, USA

Vaccines -

http://vaccinationdangers.wordpress.com/ Homeopathy

http://homeopathycures.wordpress.com

Vaccine Dangers, Childhood Disease Classes & Homeopathy

Online/email courses - next classes start March 4